ibogaine has been researched along with dihydro-beta-erythroidine in 1 studies
Studies (ibogaine) | Trials (ibogaine) | Recent Studies (post-2010) (ibogaine) | Studies (dihydro-beta-erythroidine) | Trials (dihydro-beta-erythroidine) | Recent Studies (post-2010) (dihydro-beta-erythroidine) |
---|---|---|---|---|---|
445 | 8 | 136 | 385 | 0 | 115 |
Protein | Taxonomy | ibogaine (IC50) | dihydro-beta-erythroidine (IC50) |
---|---|---|---|
Neuronal acetylcholine receptor subunit alpha-4 | Rattus norvegicus (Norway rat) | 0.0124 | |
Neuronal acetylcholine receptor subunit beta-2 | Rattus norvegicus (Norway rat) | 0.03 | |
Neuronal acetylcholine receptor subunit beta-2 | Homo sapiens (human) | 0.147 | |
Neuronal acetylcholine receptor subunit alpha-5 | Homo sapiens (human) | 0.011 | |
Neuronal acetylcholine receptor subunit alpha-4 | Homo sapiens (human) | 0.147 | |
Neuronal acetylcholine receptor subunit beta-4 | Mus musculus (house mouse) | 1.2 | |
Neuronal acetylcholine receptor subunit beta-2 | Mus musculus (house mouse) | 1.2 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 1 (100.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
de Moura, FB; McMahon, LR | 1 |
1 other study(ies) available for ibogaine and dihydro-beta-erythroidine
Article | Year |
---|---|
The contribution of α4β2 and non-α4β2 nicotinic acetylcholine receptors to the discriminative stimulus effects of nicotine and varenicline in mice.
Topics: Aconitine; Alkaloids; alpha7 Nicotinic Acetylcholine Receptor; Animals; Azocines; Benzamides; Bridged Bicyclo Compounds; Bridged Bicyclo Compounds, Heterocyclic; Cocaine; Dihydro-beta-Erythroidine; Discrimination, Psychological; Dopamine Uptake Inhibitors; Hypnotics and Sedatives; Ibogaine; Male; Mecamylamine; Mice; Mice, Inbred C57BL; Midazolam; Nerve Tissue Proteins; Nicotine; Nicotinic Agonists; Nicotinic Antagonists; Pyridines; Quinolizines; Receptors, Nicotinic; Varenicline | 2017 |